In February 2010, aztreonam for inhalation solution (Cayston; Gilead) — an inhalable formulation of the monobactam antibiotic aztreonam and lysine — was approved by the US FDA to improve ...

For further clarification, consult your healthcare provider. This medication is monobactam antibiotic, prescribed for serious infections caused by susceptible gram negative bacteria like urinary ...